March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' (LNTH.O), opens new tab prostate cancer imaging agent, aimed at improving ‌scanning ...
These Trump voters support airstrikes, oppose ground troops in Iran Confusion over rationale for strikes among Trump supporters Gas prices rise, but seen as temporary by supporters While that has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results